Literature DB >> 9831115

Gastric carcinoma.

M S Karpeh1, M F Brennan.   

Abstract

Gastric cancer continues to be a major global health problem. In the American College of Surgeons Patient Care study on gastric cancer, 5-year disease-specific survival was 26%, with an overall survival of 14%. Improvements in survival will require both earlier diagnosis and new therapeutic strategies. The ability of surgical oncologists to understand the natural history of the disease, accurately define its extent, and provide the most effective treatment places them in a key position to see that improvements in outcome are brought about expeditiously.

Entities:  

Mesh:

Year:  1998        PMID: 9831115     DOI: 10.1007/bf02303836

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  6 in total

1.  Long-term results after surgery for gastric cancer with or without jejunal reservoir: results of surgery for gastric cancer in Kanta-Häme central hospital in two consecutive periods without or with jejunal pouch reconstruction in 1985-1998.

Authors:  Hannu Paimela; Saara Ketola; Mauri Iivonen; Timo Tomminen; Esa Könönen; Niku Oksala; Harri Mustonen
Journal:  Int J Gastrointest Cancer       Date:  2005

2.  Functional interleukin-4 receptor and interleukin-2 receptor common gamma chain in human gastric carcinoma: a possible mechanism for cytokine-based therapy.

Authors:  R Essner; Y Huynh; T Nguyen; M Rose; M Kojima; D S Hoon
Journal:  J Gastrointest Surg       Date:  2001 Jan-Feb       Impact factor: 3.452

Review 3.  Gastric adenocarcinoma: review and considerations for future directions.

Authors:  Bryan J Dicken; David L Bigam; Carol Cass; John R Mackey; Anil A Joy; Stewart M Hamilton
Journal:  Ann Surg       Date:  2005-01       Impact factor: 12.969

4.  R0 resection in the treatment of gastric cancer: room for improvement.

Authors:  Alberto Biondi; Roberto Persiani; Ferdinando Cananzi; Marco Zoccali; Vincenzo Vigorita; Andrea Tufo; Domenico D'Ugo
Journal:  World J Gastroenterol       Date:  2010-07-21       Impact factor: 5.742

5.  Prognostic factors in patients with loco-regionally advanced gastric cancer.

Authors:  Bo Hultman; Ulf Gunnarsson; Peter Nygren; Magnus Sundbom; Bengt Glimelius; Haile Mahteme
Journal:  World J Surg Oncol       Date:  2017-09-15       Impact factor: 2.754

6.  Postoperative mortality and morbidity after D2 lymphadenectomy for gastric cancer: A retrospective cohort study.

Authors:  Giuseppe Brisinda; Maria Michela Chiarello; Anna Crocco; Neill James Adams; Pietro Fransvea; Serafino Vanella
Journal:  World J Gastroenterol       Date:  2022-01-21       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.